2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)

Friday, November 13, 2020

Join us as we discuss today’s pressing healthcare issues.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005535/en/

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

CO-HOSTS:

Bunny Ellerin

Jing He

Director, HPM, Columbia Business School
Biotech Analyst, Gabelli Funds

• MBA, Harvard Business School

• MBA, Columbia Business School

• BA, Columbia University

• MA, Washington University in St. Louis

• BS, Peking University

Time

Agenda

9:00 – 9:10 AM

Welcome

• Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program

9:10 – 10:00 AM

Vaccines & Therapeutics to Treat COVID-19

• David Hering, Regional President, North America, Pfizer Vaccines

• Dr. Jacqueline Miller, Senior Vice President, Infectious Diseases, Moderna

• Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron

• (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds

10:10 – 11:00 AM

Health Policy & Reimbursement Trends

• Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, New York-Presbyterian

• Melissa Schulman, Senior Vice President of Government Affairs, CVS Health

• Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health

• (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds

11:10 – Noon

Healthcare Delivery in a Virtual World

• Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery

• Jason Gorevic, CEO, Teladoc Health

• Dr. Julie Silverstein, Divisional President, Oak Street Health

• (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).

View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005535/en/

Douglas R. Jamieson 914-921-5020 [e-mail]